klini^ko ispituvawe na terapiskata efikasnost, podnoslivost i

Clinical trial on terapeutic efficacy, tolerability and safety of peroral solutions Varumin 1 and 2 (Interevrogeneks)
in a combined treatment with polyvitamin – antioxidative therapy in patients with biologicaly
(PCR) detected HPV infection of high-risk type, with or without biopticaly verified CIN I
Hall AH, Spoerke DG, Rumack BH. Assessing mistletoe toxicity. Ann Emerg Med. 1986;
15:1320-1323
Happle R. Alternative medicine: really an alternative to academic medicine? Hautarzt.
2000;51:439-443
Hassauer W, Gutsch J, Burkhardt R. What prospects of success does Iscador therapy offer in
advanced ovarian cancer? Onkologie. 1979;2:28-36
Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, et al. A Phase III study on the
efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 2002 Dec;25(6):442-51
Helzlsouer K, Huang H, Alberg A, Hoffman S, Burke A, Norkus E, Morris J, Comstock G (2000).
"Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate
cancer". J Natl Cancer Inst 92 (24): 2018–23. doi:10.1093/jnci/92.24.2018. PMID 11121464
Heinrich M., Barnes J., Gibbons S., Williamson E., Fundamentals of Pharmacognosy and
Phytotherapy, Churcill Livingstone, Edinburg, London, New York, Oxford, Philadelphia, St Luis,
Sydney, Toronto, 2004.
Hoening J. et al., 1992 in Assessment report on Aloe barbadensis and aloe (various species, mainly
Aloe ferox Mill. And its hybrids), EMEA/HMPC, Doc. Ref. 76313/2007.
Holme SA, Roberts DL. Erythroderma associated with St John's wort. Br J Dermatol. Nov
2000;143(5):1127-1128
Hording U, Rygaard C, Ruge S, Felding C, Lundvall F, Junge J. Cervical koilocytosis and high
risk HPV types: the benefit of laser vaporization. Eur J Obstet Gynecol Reprod Biol
1993;51(2):125-30.
Huber R., Eisenbraun J., Miletzki B., Adler M., Gleiter C.H., Pharmacokinetics of mistletoe lectins
– a phase I study, int. J. Phytoth. Phytopharm., 2007 (http://findarticles.com).
Huber R, Klein R, Berg PA, et al. Effects of a lectin- and a viscotoxin-rich mistletoe preparation
on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects. J
Altern Complement Med. 2002;8:857-866.
Huber R, et al. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C:
an individually controlled cohort study. Eur J Med Res 2001;6:399-405
Hulsen H., Mechelke F., In vitro effectiveness of a mistletoe preparation on cytostatic - drug -
resistant human leukemia cells, Naturwissenschaffen, 74, 144 - 145, 1987.
University Gynecology and Obstetrics Clinic, Vodnjanska bb, University St. Cyrillus and Methodius, Skopje,
Macedonia
52